Ryoji Yoshida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ryoji Yoshida has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
- Hideki Nakayama
Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences Kumamoto University Kumamoto Japan
16 shared publications Kenta Kawahara
15 shared publicationsAkiyuki Hirosue
14 shared publicationsMasatoshi Hirayama
Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences Kumamoto University Kumamoto Japan
12 shared publicationsHidetaka Arita
Section of Oral Oncology Fukuoka Dental College Fukuoka Japan
9 shared publicationsKeisuke Yamana
9 shared publications
Latest Publications
- Open Access
- 11 August 2026
- Published by Wiley in Cancer Reports
- Vol. 9 (8) , e70654
SMAD4 Expression and Its Association With Treatment Resistance and Clinical Outcomes in Oral Squamous Cell Carcinoma Treated With Preoperative Chemoradiotherapy
Background: Small mothers against decapentaplegic homologue 4 (SMAD4) plays an important role in transforming growth factor (TGF)‐β signaling and is associated with various cancers. However, little is known about SMAD4 expression in oral squamous cell carcinoma (OSCC). Aim: To investigate the clinical and biological significance of SMAD4 expression in OSCC. Methods and Results: Immunohistochemical analysis was performed to detect SMAD4 expression in 90 OSCC specimens obtained from patients who underwent preoperative chemoradiotherapy and surgery (phase II study). We also investigated the correlation between SMAD4 expression and various clinicopathological features. In vitro experiments were performed to assess the effects of SMAD4 expression on chemosensitivity and changes in apoptosis‐related molecules. Notably, low SMAD4 expression was significantly correlated with an increased risk of lymph node metastasis, poor response to chemoradiotherapy, and adverse prognosis in patients with OSCC who underwent preoperative 5‐FU‐based chemoradiotherapy. Additionally, SMAD4 downregulation in OSCC cells decreased sensitivity to cisplatin and 5‐fluorouracil and was associated with an increase in cIAP2 expression. Conclusion: The reduced expression of SMAD4 has been linked to both chemotherapy resistance and prognosis in OSCC. However, it may not function as an independent prognostic biomarker. Further research is necessary to determine whether these findings can be generalized to the broader OSCC population.
- 11 August 2026
- Published by Wiley in Cancer Reports
- Vol. 9 (8) , e70654
Open AccessSMAD4 Expression and Its Association With Treatment Resistance and Clinical Outcomes in Oral Squamous Cell Carcinoma Treated With Preoperative Chemoradiotherapy
Background: Small mothers against decapentaplegic homologue 4 (SMAD4) plays an important role in transforming growth factor (TGF)‐β signaling and is associated with various cancers. However, little is known about SMAD4 expression in oral squamous cell carcinoma (OSCC). Aim: To investigate the clinical and biological significance of SMAD4 expression in OSCC. Methods and Results: Immunohistochemical analysis was performed to detect SMAD4 expression in 90 OSCC specimens obtained from patients who underwent preoperative chemoradiotherapy and surgery (phase II study). We also investigated the correlation between SMAD4 expression and various clinicopathological features. In vitro experiments were performed to assess the effects of SMAD4 expression on chemosensitivity and changes in apoptosis‐related molecules. Notably, low SMAD4 expression was significantly correlated with an increased risk of lymph node metastasis, poor response to chemoradiotherapy, and adverse prognosis in patients with OSCC who underwent preoperative 5‐FU‐based chemoradiotherapy. Additionally, SMAD4 downregulation in OSCC cells decreased sensitivity to cisplatin and 5‐fluorouracil and was associated with an increase in cIAP2 expression. Conclusion: The reduced expression of SMAD4 has been linked to both chemotherapy resistance and prognosis in OSCC. However, it may not function as an independent prognostic biomarker. Further research is necessary to determine whether these findings can be generalized to the broader OSCC population.
- Open Access
- 23 January 2026
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 38 (4) , 604-611
Age-related differences in tongue squamous cell carcinoma: Insights from propensity score-matched analyses
- 23 January 2026
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 38 (4) , 604-611
Open AccessAge-related differences in tongue squamous cell carcinoma: Insights from propensity score-matched analyses
- Open Access
- 11 July 2025
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 30 (9) , 1775-1786
Pterygomandibular raphe invasion as a novel grading and prognostic factor for squamous cell carcinoma of buccal mucosa: a retrospective study with propensity score matching
Background: Squamous cell carcinoma of the buccal mucosa (SCCBM) is a prevalent malignancy of the oral cavity with high morbidity and mortality rates. The pterygomandibular raphe (PMR) connects the oral cavity, pharynx, and masticator space, serving as a key anatomical landmark during surgical resection. However, PMR invasion into SCCBM remains poorly understood. This study assessed the prognostic significance of PMR invasion in patients with resectable SCCBM. Methods: The study included 82 patients with SCCBM, excluding those with T4b, who underwent radical resection at Kumamoto University Hospital between 2000 and 2017. Patients were categorized into three groups based on PMR invasion patterns: non-contact, contact, and invasion. The relationship between PMR invasion and clinicopathological characteristics was analyzed using the Fisher’s exact test. The Kaplan–Meier method, log-rank test, and propensity score-matched analyses were used for survival analysis. Results: Contact or invasion into the PMR was significantly associated with advanced clinical T and N stages, clinical stage, endophytic growth pattern, high-grade invasion pattern, and poor tumor differentiation. Patients with PMR invasion had a higher proportion of recurrences in the buccal subcutaneous, mandibular, and masticator spaces. Univariate analysis indicated that contact- or invasion-type PMR invasion predicted worse overall survival (OS). The impact of PMR invasion on OS was confirmed using a propensity score-matched analysis. Conclusion: This study revealed that PMR invasion is a potential novel grading and prognostic factor for resectable SCCBM, with significance in planning the extent of SCCBM resection.
- 11 July 2025
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 30 (9) , 1775-1786
Open AccessPterygomandibular raphe invasion as a novel grading and prognostic factor for squamous cell carcinoma of buccal mucosa: a retrospective study with propensity score matching
Background: Squamous cell carcinoma of the buccal mucosa (SCCBM) is a prevalent malignancy of the oral cavity with high morbidity and mortality rates. The pterygomandibular raphe (PMR) connects the oral cavity, pharynx, and masticator space, serving as a key anatomical landmark during surgical resection. However, PMR invasion into SCCBM remains poorly understood. This study assessed the prognostic significance of PMR invasion in patients with resectable SCCBM. Methods: The study included 82 patients with SCCBM, excluding those with T4b, who underwent radical resection at Kumamoto University Hospital between 2000 and 2017. Patients were categorized into three groups based on PMR invasion patterns: non-contact, contact, and invasion. The relationship between PMR invasion and clinicopathological characteristics was analyzed using the Fisher’s exact test. The Kaplan–Meier method, log-rank test, and propensity score-matched analyses were used for survival analysis. Results: Contact or invasion into the PMR was significantly associated with advanced clinical T and N stages, clinical stage, endophytic growth pattern, high-grade invasion pattern, and poor tumor differentiation. Patients with PMR invasion had a higher proportion of recurrences in the buccal subcutaneous, mandibular, and masticator spaces. Univariate analysis indicated that contact- or invasion-type PMR invasion predicted worse overall survival (OS). The impact of PMR invasion on OS was confirmed using a propensity score-matched analysis. Conclusion: This study revealed that PMR invasion is a potential novel grading and prognostic factor for resectable SCCBM, with significance in planning the extent of SCCBM resection.
- Open Access
- 15 May 2025
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 37 (6) , 1186-1195
Osteopontin derived from tumor-associated macrophages modulates radiosensitivity of oral squamous cell carcinoma via reactive oxygen species production
- 15 May 2025
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 37 (6) , 1186-1195
Open AccessOsteopontin derived from tumor-associated macrophages modulates radiosensitivity of oral squamous cell carcinoma via reactive oxygen species production
- Open Access
- 5 January 2025
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 37 (4) , 631-638
Exosome-derived miR-1290 in blood as a predictive biomarker for occult neck metastasis in patients with cT1-2N0 tongue cancer
- 5 January 2025
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 37 (4) , 631-638
Open AccessExosome-derived miR-1290 in blood as a predictive biomarker for occult neck metastasis in patients with cT1-2N0 tongue cancer
- 21 March 2024
- Published by Elsevier in Oral Oncology
- Vol. 151, 106752
Radiation Therapy Oncology Group 8502 “QUAD shot” regimen using volumetric modulated arc therapy for incurable head and neck cancer
- 21 March 2024
- Published by Elsevier in Oral Oncology
- Vol. 151, 106752
Radiation Therapy Oncology Group 8502 “QUAD shot” regimen using volumetric modulated arc therapy for incurable head and neck cancer
- Open Access
- 20 December 2023
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 36 (4) , 518-525
Programmed death-ligand 1-expressing extracellular vesicles are a prognostic factor in patients with oral squamous cell carcinoma treated with immune checkpoint inhibitors
- 20 December 2023
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 36 (4) , 518-525
Open AccessProgrammed death-ligand 1-expressing extracellular vesicles are a prognostic factor in patients with oral squamous cell carcinoma treated with immune checkpoint inhibitors
- Open Access
- 10 January 2023
- Published by Elsevier in Laboratory Investigation
- Vol. 103 (5) , 100060
FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells
- 10 January 2023
- Published by Elsevier in Laboratory Investigation
- Vol. 103 (5) , 100060
Open AccessFOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells
- Open Access
- 8 October 2022
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 27, 141-156
An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma
- 8 October 2022
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 27, 141-156
Open AccessAn oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma